Trial Outcomes & Findings for Use of Color Doppler in Routine Examination of Fetal Heart in Second Trimester (NCT NCT01201486)

NCT ID: NCT01201486

Last Updated: 2016-04-27

Results Overview

The number of \*fetuses with\* heart defects detected by color Doppler in the second trimester was compared to the number of \*fetuses with\* major heart defects detected at birth.

Recruitment status

COMPLETED

Target enrollment

6781 participants

Primary outcome timeframe

2nd trimester

Results posted on

2016-04-27

Participant Flow

Participant milestones

Participant milestones
Measure
Pregnant Women in Second Trimester
Pregnant females in the 2nd trimester.
Overall Study
STARTED
6781
Overall Study
COMPLETED
6781
Overall Study
NOT COMPLETED
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Use of Color Doppler in Routine Examination of Fetal Heart in Second Trimester

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Pregnant Women in Second Trimester
n=6781 Participants
Pregnant females in the 2nd trimester.
Age, Continuous
29 years
n=5 Participants
Sex: Female, Male
Female
6781 Participants
n=5 Participants
Sex: Female, Male
Male
0 Participants
n=5 Participants

PRIMARY outcome

Timeframe: 2nd trimester

The number of \*fetuses with\* heart defects detected by color Doppler in the second trimester was compared to the number of \*fetuses with\* major heart defects detected at birth.

Outcome measures

Outcome measures
Measure
Pregnant Women
n=6781 Participants
Pregnant females in the 2nd trimester.
Sensitivity of Color Doppler Examination to Detect Major Heart Defects During the Second Trimester of Pregnancy
Major Heart Defects at Delivery
39 fetuses
Sensitivity of Color Doppler Examination to Detect Major Heart Defects During the Second Trimester of Pregnancy
Heart Defects Detected by Color Dopple
9 fetuses

Adverse Events

Pregnant Women

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Torbjørn Moe Eggebø, phd

StavangerUH

Phone: 004792699433

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place